IndraLab

Statements


USP22 deubiquitinates HIF1A. 3 / 3
1 | 2

"RESULTS: <span class="match term0">USP22</span> promotes hypoxia-induced HCC stemness and glycolysis by deubiquitinating and stabilising <span class="match term1">HIF1ALPHA</span>"

reach
"A new study reveals that USP22 promotes the pathological process of myocardial hypertrophy by deubiquitinating HIF-1a and further activate the TAK1-(JNK1/2)/P38 signaling pathway [75]."

reach
"USP22 promotes the pathological process of myocardial hypertrophy by deubiquitinating HIF-1a which further activate the TAK1-(JNK1/2)/p38 signaling pathway [75]."